78 related articles for article (PubMed ID: 30478785)
1. G-protein-coupled estrogen receptor GPER-1 expression in hormone receptor-positive breast cancer is associated with poor benefit of tamoxifen.
Ignatov T; Claus M; Nass N; Haybaeck J; Seifert B; Kalinski T; Ortmann O; Ignatov A
Breast Cancer Res Treat; 2019 Feb; 174(1):121-127. PubMed ID: 30478785
[TBL] [Abstract][Full Text] [Related]
2. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers.
Witkiewicz AK; Dasgupta A; Sotgia F; Mercier I; Pestell RG; Sabel M; Kleer CG; Brody JR; Lisanti MP
Am J Pathol; 2009 Jun; 174(6):2023-34. PubMed ID: 19411448
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen.
Winder T; Giamas G; Wilson PM; Zhang W; Yang D; Bohanes P; Ning Y; Gerger A; Stebbing J; Lenz HJ
Pharmacogenomics J; 2014 Feb; 14(1):28-34. PubMed ID: 23459444
[TBL] [Abstract][Full Text] [Related]
4. GPR30, the non-classical membrane G protein related estrogen receptor, is overexpressed in human seminoma and promotes seminoma cell proliferation.
Chevalier N; Vega A; Bouskine A; Siddeek B; Michiels JF; Chevallier D; Fénichel P
PLoS One; 2012; 7(4):e34672. PubMed ID: 22496838
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk prediction.
Baneshi MR; Warner P; Anderson N; Edwards J; Cooke TG; Bartlett JM
Br J Cancer; 2010 May; 102(10):1503-10. PubMed ID: 20461093
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen enhances stemness and promotes metastasis of ERα36
Wang Q; Jiang J; Ying G; Xie XQ; Zhang X; Xu W; Zhang X; Song E; Bu H; Ping YF; Yao XH; Wang B; Xu S; Yan ZX; Tai Y; Hu B; Qi X; Wang YX; He ZC; Wang Y; Wang JM; Cui YH; Chen F; Meng K; Wang Z; Bian XW
Cell Res; 2018 Mar; 28(3):336-358. PubMed ID: 29393296
[TBL] [Abstract][Full Text] [Related]
7. Current progress and prospects for G protein-coupled estrogen receptor in triple-negative breast cancer.
Zhang D; Chen H; Wang J; Ji J; Imam M; Zhang Z; Yan S
Front Cell Dev Biol; 2024; 12():1338448. PubMed ID: 38476263
[TBL] [Abstract][Full Text] [Related]
8. Association between
Ulhaq ZS; Soraya GV; Milliana A; Tse WKF
Heliyon; 2021 Mar; 7(3):e06428. PubMed ID: 33748487
[TBL] [Abstract][Full Text] [Related]
9. Positive correlation between the nuclear expression of GPER and pGLI3 in prostate cancer tissues from patients with different Gleason scores.
Rico-Fuentes C; López-Pulido EI; Pérez-Guerrero EE; Godínez-Rubí M; Villegas-Pineda JC; Villanueva-Pérez MA; Sierra-Díaz E; Zepeda-Nuño JS; Pereira-Suárez AL; Ramírez-de-Arellano A
Front Endocrinol (Lausanne); 2024; 15():1333284. PubMed ID: 38370352
[TBL] [Abstract][Full Text] [Related]
10. GPER governs the immune infiltration of gastric cancer and activates the NF-κB/ROS/Apoptosis pathway in gastric mucosal epithelium.
Yang X; Zhang J; Ma J; Huang J; Wang Y; Wang P; Wang F; Tang X
Int Immunopharmacol; 2023 Sep; 122():110641. PubMed ID: 37487261
[TBL] [Abstract][Full Text] [Related]
11. Role of tamoxifen in idiopathic gynecomastia: A 10-year prospective cohort study.
Mannu GS; Sudul M; Bettencourt-Silva JH; Tsoti SM; Cunnick G; Ahmed SF
Breast J; 2018 Nov; 24(6):1043-1045. PubMed ID: 30079473
[TBL] [Abstract][Full Text] [Related]
12. Stimulatory Anticancer Effect of Resveratrol Mediated by G Protein-Coupled Estrogen Receptor in Colorectal Cancer.
Kim N; Kwon J; Shin US; Jung J
Biomol Ther (Seoul); 2023 Nov; 31(6):655-660. PubMed ID: 37817377
[TBL] [Abstract][Full Text] [Related]
13. Analysis of human GPER expression in normal tissues and select cancers using immunohistochemistry.
Natale CA; Seykora JT; Ridky TW
bioRxiv; 2023 Mar; ():. PubMed ID: 36945570
[TBL] [Abstract][Full Text] [Related]
14. Commentary: harnessing the first peptidic modulator of the estrogen receptor GPER.
Lappano R; Maggiolini M; Mallet C; Jacquot Y
Front Pharmacol; 2024; 15():1413058. PubMed ID: 38751778
[No Abstract] [Full Text] [Related]
15. GPER is a mechanoregulator of pancreatic stellate cells and the tumor microenvironment.
Cortes E; Sarper M; Robinson B; Lachowski D; Chronopoulos A; Thorpe SD; Lee DA; Del Río Hernández AE
EMBO Rep; 2019 Jan; 20(1):. PubMed ID: 30538117
[TBL] [Abstract][Full Text] [Related]
16. G protein-coupled receptor 119 is involved in RANKL-induced osteoclast differentiation and fusion.
Kim HJ; Yoon HJ; Park JW; Che X; Jin X; Choi JY
J Cell Physiol; 2019 Jul; 234(7):11490-11499. PubMed ID: 30478996
[TBL] [Abstract][Full Text] [Related]
17. GPER-Induced ERK Signaling Decreases Cell Viability of Hepatocellular Carcinoma.
Qiu YA; Xiong J; Fu Q; Dong Y; Liu M; Peng M; Jin W; Zhou L; Xu X; Huang X; Fu A; Xu G; Tu G; Yu T
Front Oncol; 2021; 11():638171. PubMed ID: 33767999
[TBL] [Abstract][Full Text] [Related]
18. Continuous Exposure of Breast Cancer Cells to Tamoxifen Upregulates GPER-1 and Increases Cell Proliferation.
Molina L; Bustamante F; Ortloff A; Ramos I; Ehrenfeld P; Figueroa CD
Front Endocrinol (Lausanne); 2020; 11():563165. PubMed ID: 33117280
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
